Patanjali launches Coronil – Ayurvedic tablets to treat COVID-19


Patanjali Ayurved, headed by the Yog-guru Baba Ramdev, has announced the launch of Coronil tablets, that is a Ayurvedic formulation to treat Coronavirus.

The company claims it has launched the product after evidence-based testing that the formulation works to treat the novel coronavirus that has so far affected 9 million globally. The product is being manufactured in Haridwar by Divya Pharmacy, the manufacturing unit of Patanjali Yogpeeth.

Taking to Twitter, the company’s CEO Acharya Balakrishna wrote: “Proud launch of first and foremost evidence-based ayurvedic medicine for #corona contagion, #SWASARI_VATI, #CORONIL, is scheduled for tomorrow at 12 noon from #Patanjali Yogpeeth Haridwar.”

Image courtesy of @The_Akshay_1 via Twitter

Earlier this month, the company claimed that the Ayurvedic formulation can down the virus within 14-days. “We appointed a team of scientists after the Covid-19 outbreak. First, the simulation was done and compounds were identified which can fight the virus and stop its spread in the body. Then, we conducted a clinical case study on hundreds of positive patients and we have got 100 percent favorable results,” the CEO of Patanjali Ayurved was earlier quoted as saying.

Patanjali’s anti-COVID tablet is made from Ashwagandha, Giloy, and tulsi and is being prescribed to take thrice a day, 30-mins prior breakfast, lunch and dinner, with warm water. For children, the dosage is prescribed at half the dose for adults, according to reports.

Patanjali’s launch comes at a time when the world is racing to land on the first vaccine of the novel coronavirus that originated in Wuhan, China. So far, the virus has infected 9 million cases across the world, with both the Americas leading the pack.